接受化疗的癌症患者的抑郁症状：一项心理测量分析。
Depressive symptoms in cancer patients undergoing chemotherapy: a psychometric analysis.
作者信息
Middelboe T, Ovesen L, Mortensen E L, Bech P
机构信息
Department of Psychiatry, Bispebjerg University Hospital, Copenhagen, Denmark.
出版信息
Psychother Psychosom. 1994;61(3-4):171-7. doi: 10.1159/000288886.
Depressive psychopathology was measured in a prospective follow-up study of 36 cancer patients. The psychometric properties of the Hamilton rating scales for depression and anxiety and the Melancholia Scale were examined. The scales proved useful, indicating that the symptomatic structure of depression in cancer patients is rather identical to that seen in primary depression. Depressive states were found in about 40% of patients before the start of chemotherapy. The frequency of intermediate and high scores on the depression scales showed a low to moderate decrease after 6 months. Aspects of depression in the medically ill are discussed, and screening routines suggested.
在一项对36名癌症患者的前瞻性随访研究中，对抑郁精神病理学进行了测量。研究考察了汉密尔顿抑郁与焦虑评定量表以及忧郁症量表的心理测量特性。结果表明这些量表很有用，这意味着癌症患者抑郁的症状结构与原发性抑郁症患者的症状结构相当一致。在化疗开始前，约40%的患者存在抑郁状态。抑郁量表中、高分的频率在6个月后呈低到中度下降。文中讨论了内科疾病患者抑郁的相关方面，并提出了筛查程序。
Zotero 插件